A study released Friday found that kid-size doses of Pfizer’s Covid vaccine are nearly 91 percent effective at preventing symptomatic infections in 5- to 11-year-olds.
Related Articles
-
Writing by hand may increase brain connectivity more than typing, readings of student brains suggest
Typing may be faster than writing by hand, but it’s less stimulating for the brain, according to research published...
-
Do Covid treatments work against the omicron subvariant? Scientists keep close watch
Scientists are keeping a close watch on BA.2, a subvariant of the omicron variant, as it spreads through the...
-
CEO running Philly’s once-largest vaccination site accused of taking doses home
The 22-year-old CEO of Philly Fighting COVID, a group that ran the city’s biggest Covid-19 vaccination site, has been...
-
Cholera outbreak in Zimbabwe suspected in 150 deaths as disease spreads throughout country
HARARE, Zimbabwe — These days, Catherine Mangosho locks her 3-year-old grandson in the house for hours on end in...
-
‘The collateral damage of Covid-19’: Hospitals see rise in alcohol-related liver disease
Just months into the pandemic, Kelly White, a 52-year-old mother of three, found herself extremely nauseous and unable to...
-
Oprah says she takes weight-loss medication and had to get over ‘shame’ about using it
Oprah Winfrey’s slimmed-down frame can be credited to weight loss medication and a holistic approach, the media mogul told...
-
A stark social divide: Adults without a college degree more likely to have no close friends
The Summary In a survey, nearly a quarter of U.S. adults without a college degree said they had no...
-
State Dept. names new chief of task force overseeing ‘Havana Syndrome’ response
Secretary of State Antony Blinken on Friday named a new diplomat to lead a task force overseeing the response...
Recent Comments